ADAM12-s in coelomic fluid and maternal serum in early pregnancy

George Makrydimas1, Alexandros Sotiriadis, Kevin Spencer

  • 1Department of Obstetrics and Gynaecology, Ioannina University Hospital, 45500 Ioannina, Greece.

Prenatal Diagnosis
|December 2, 2006
PubMed

Insights

Maternal serum ADAM12-s levels increase with gestation in early pregnancy. This placental protein was detected in maternal serum and coelomic fluid, but not amniotic fluid, supporting its syncytiotrophoblast origin.

Area of Science:

  • Reproductive biology
  • Maternal-fetal medicine
  • Biochemistry

Background:

  • ADAM12-s is a placental protein linked to adverse pregnancy outcomes like trisomy, pre-eclampsia, and fetal growth restriction.
  • Understanding ADAM12-s distribution in early pregnancy is crucial for potential diagnostic applications.

Purpose of the Study:

  • To investigate the distribution of ADAM12-s in maternal serum, amniotic fluid, and coelomic fluid during early pregnancy.
  • To compare ADAM12-s concentrations across these different biological compartments.

Main Methods:

  • Coelomic fluid, maternal serum, and amniotic fluid samples were collected from 13 singleton pregnancies (6.9-9.3 weeks gestation).
  • ADAM12-s concentrations were quantified using dissociation-enhanced lanthanide fluoro-immunoassay (DELFIA).

Main Results:

  • Median ADAM12-s concentration was 132.7 ng/mL in maternal serum and 10.5 ng/mL in coelomic fluid.
  • Detectable ADAM12-s levels were absent in most amniotic fluid samples (5/6).
  • Maternal serum ADAM12-s significantly correlated with gestational age (r=0.862, p<0.0001).

Conclusions:

  • The presence of ADAM12-s in maternal serum and coelomic fluid supports its origin from the syncytiotrophoblast.
  • ADAM12-s distribution patterns in early pregnancy warrant further investigation for clinical relevance.
Abstract

Related Concept Videos

Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Transcytosis of IgG01:15

Transcytosis of IgG

Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
Fetal Circulation01:14

Fetal Circulation

Fetal circulation is a unique system that facilitates the exchange of gases, nutrients, and waste products between the developing fetus and the mother. This intricate process takes place through a special organ called the placenta.
Two umbilical arteries transport blood from the fetus to the placenta. At the placenta, the blood absorbs oxygen and nutrients while simultaneously eliminating waste products. This oxygen-enriched and nutrient-rich blood then returns to the fetus through one...